G. Szilágyi

1.2k total citations
85 papers, 821 citations indexed

About

G. Szilágyi is a scholar working on Organic Chemistry, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, G. Szilágyi has authored 85 papers receiving a total of 821 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Organic Chemistry, 24 papers in Endocrinology, Diabetes and Metabolism and 16 papers in Molecular Biology. Recurrent topics in G. Szilágyi's work include Synthesis and Characterization of Heterocyclic Compounds (14 papers), Synthesis and biological activity (9 papers) and Thyroid Disorders and Treatments (9 papers). G. Szilágyi is often cited by papers focused on Synthesis and Characterization of Heterocyclic Compounds (14 papers), Synthesis and biological activity (9 papers) and Thyroid Disorders and Treatments (9 papers). G. Szilágyi collaborates with scholars based in Hungary, Germany and Sweden. G. Szilágyi's co-authors include Zsolt Nagy, I. Szabolcs, Orsolya Dohán, Miklós Góth, L Simón, Heinrich Wamhoff, Balázs Gulyás, László Kovács, Ádám Vas and Zoltán Bori and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Neurochemistry and Tetrahedron.

In The Last Decade

G. Szilágyi

79 papers receiving 768 citations

Peers

Countries citing papers authored by G. Szilágyi

Since Specialization

Citations

This map shows the geographic impact of G. Szilágyi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Szilágyi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Szilágyi more than expected).

Fields of papers citing papers by G. Szilágyi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Szilágyi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Szilágyi. The network helps show where G. Szilágyi may publish in the future.

Co-authorship network of co-authors of G. Szilágyi

This figure shows the co-authorship network connecting the top 25 collaborators of G. Szilágyi. A scholar is included among the top collaborators of G. Szilágyi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Szilágyi. G. Szilágyi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Correlation between crossed cerebellar diaschisis and clinical neurological scales 2011 ·Acta Neurologica Scandinavica ·G. Szilágyi, Ádám Vas, Levente Kerényi, Zsolt Nagy, László Csiba, Balázs Gulyás	33
2	Neuroprotective effects of estrogen treatment on ischemia-induced behavioural deficits in ovariectomized gerbils at different ages 2010 ·Behavioural Brain Research ·Edina A. Wappler-Guzzetta, Klára Felszeghy, G. Szilágyi, Anikó Gál, (unknown), Raj D. Mehra, Csaba Nyakas, Zsolt Nagy	20
3	(−)Deprenyl-N-oxide, a (−)deprenyl metabolite, is cytoprotective after hypoxic injury in PC12 cells, or after transient brain ischemia in gerbils 2009 ·Journal of the Neurological Sciences ·G. Szilágyi, L Simón, Edina A. Wappler-Guzzetta, K. Magyar, Zsolt Nagy	8
4	The efficacy of long term thyrostatic treatment in elderly patients with toxic nodular goitre compared to radioiodine therapy with different doses 2009 ·Experimental and Clinical Endocrinology & Diabetes ·(unknown), I. Szabolcs, J Földes, (unknown), Andrea Ferencz, (unknown), Miklós Góth, Orsolya Dohán, László Kovács, G. Szilágyi	5
5	Apoplexy of a pituitary macroadenoma as a severe complication of preoperative thyrotropin-releasing hormone (TRH) testing 2009 ·Experimental and Clinical Endocrinology & Diabetes ·I. Szabolcs, (unknown), (unknown), Sándor Czirják, Orsolya Dohán, (unknown), Miklós Góth, László Kovács, Andrea Ferencz, (unknown), G. Szilágyi	6
6	Bcl-2 or Bcl-XL gene therapy reduces apoptosis and increases plasticity protein GAP-43 in PC12 cells 2007 ·Brain Research Bulletin ·Anikó Gál, G. Szilágyi, Edina A. Wappler-Guzzetta, Géza Sáfrány, Zsolt Nagy	9
7	Continuous Monitoring of Post Mortem Temperature Changes in the Human Brain 2006 ·Neurochemical Research ·Balázs Gulyás, (unknown), G. Szilágyi, (unknown), György Székely	12
8	Visualization of mitochondrial membrane potential and reactive oxygen species via double staining 2006 ·Neuroscience Letters ·G. Szilágyi, L Simón, (unknown), (unknown), Zsolt Nagy	35
9	Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET study 2005 ·Journal of the Neurological Sciences ·G. Szilágyi, Zsolt Nagy, László Balkay, István Boros, (unknown), Szabolcs Lehel, Teréz Márián, Tamás Molnár, Szabolcs Szakáll, Lajos Trón, Dániel Bereczki, László Csiba, István Fekete, Levente Kerényi, László Galuska, József Varga, (unknown), Ádám Vas, Balázs Gulyás	41
10	(−)-d-Deprenyl attenuates apoptosis in experimental brain ischaemia 2001 ·European Journal of Pharmacology ·L Simón, G. Szilágyi, Zoltán Bori, (unknown), Zsolt Nagy	31
11	[The cumulative risk index in stroke prevention]. 2000 ·PubMed ·G. Szilágyi, T Szamosi, (unknown), (unknown), Zsolt Nagy	1
12	Comparative screening for thyroid disorders in old age in areas of iodine deficiency, long‐term iodine prophylaxis and abundant iodine intake 1997 ·Clinical Endocrinology ·I. Szabolcs, J Podoba, Joachim Feldkamp, Orsolya Dohán, I Farkas, (unknown), (unknown), Miklós Góth, László Kovács, (unknown), P Hnilica, G. Szilágyi	103
13	Diagnosis from Thyroid Aspirates 1997 ·Acta Cytologica ·I. Szabolcs, (unknown), Orsolya Dohán, Miklós Góth, László Kovács, G. Szilágyi	1
14	Prevalence of thyroid dysfunction in different geriatric subpopulations from a moderately iodine-deficient Hungarian region. Comparative clinical and hormonal screening 1995 ·European Journal of Endocrinology ·I. Szabolcs, (unknown), (unknown), (unknown), Miklós Góth, Orsolya Dohán, László Kovács, G. Szilágyi	6
15	Changes in adrenocortical lipid fluidity of hyperfunctioning human adrenals 1992 ·The Journal of Steroid Biochemistry and Molecular Biology ·E. Orsó, (unknown), Dóra Szabó, G. Szilágyi	2
16	A Facile Synthesis of 1,5‐Diphenyl‐3‐(substituted oxy)‐1H‐1,2,4‐triazoles 1990 ·Archiv der Pharmazie ·L. Czollner, G. Szilágyi, József Langó, (unknown)	4
17	1,2,4‐Triazoles, VI¹⁾: Synthesis of New 1,5‐Diphenyl‐3‐H‐1,2,4‐triazoles Substituted with H‐, Alkyl, or Carboxyl Groups at C‐3 1990 ·Archiv der Pharmazie ·L. Czollner, G. Szilágyi, József Langó, (unknown)	28
18	Liquid crystal thermography of the thyroid. 1985 ·PubMed ·(unknown), I. Szabolcs, (unknown), (unknown), (unknown), Miklós Góth, G. Szilágyi	1
19	Oat-cell bronchial carcinoma and catecholamine production. 1971 ·BMJ ·(unknown), G. Szilágyi, (unknown), L. Gráf, (unknown)	5
20	Fungus infections at Montefiore Hospital and Medical Center. 1966 ·PubMed ·G. Szilágyi, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact